Following the adaptation of the European production standard EU-GMP, Panaxia will start production in the local facility in Malta. Obtaining the license allows.
- Net Israeli revenues in 2021 increased 38% to 83.6 million. - Initial revenues from medical cannabis oils export from Israel, which began at the end of 2020,.
/PRNewswire/ Panaxia Global, the controlling owner of Panaxia Labs Israel Ltd. (TASE: PNAX), a global pharma company that develops, manufactures and markets.
/PRNewswire/ Panaxia Global, the controlling owner of Panaxia Labs Israel Ltd. (TASE: PNAX), a global pharma company that develops, manufactures and markets.